BriaCell Therapeutics Investor Presentation 2022

Loading viewer...

investor_presentation

Format: PDF investor_presentation

BriaCell Therapeutics Corp. (Nasdaq: BCTX) presents its Winter 2022 investor deck highlighting novel therapeutic development focused on cancer treatment. The company outlines its capitalization structure, market position, and forward-looking clinical development strategy.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from BriaCell Therapeutics Corp.

View all →

BriaCell Therapeutics BCTX 2021 Cancer Immunotherapy Investor Presentation

investor_presentation

17 Pages

BriaCell Therapeutics BCTX Investor Presentation 2023

investor_presentation

Similar investor_presentations from other companies

Browse all →

Teva Pharmaceutical Industries Investor Presentation — February 2020

investor_presentation

47 Pages

Teva Pharmaceutical Industries

PolyOne Corporation Investor Presentation 2018

investor_presentation